| Rebecca M Montgomery, CNM | |
|
90 Washington St, Barre, VT 05641-4239 | |
| (802) 476-6696 | |
| Not Available |
| Full Name | Rebecca M Montgomery |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 25 Years |
| Location | 90 Washington St, Barre, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851345854 | NPI | - | NPPES |
| 1007432 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 1010024494 (Vermont) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vermont Gynecology Pc | 0244428357 | 7 |
News Archive
A red dye derived from lichens that has been used for centuries to color fabrics and food appears to reduce the abundance of small toxic protein aggregates in Alzheimer's disease. The dye, a compound called orcein, and a related substance, called O4, bind preferentially to small amyloid aggregates that are considered to be toxic and cause neuronal dysfunction and memory impairment in Alzheimer's disease.
Kennedy Krieger Institute announced today new study results showing an early marker for later communication and social delays in infants at a higher-risk for autism may be infrequent gazing at other people when unprompted. Published in the September issue of the Journal of Child Psychology and Psychiatry, the study also found that six-month-old high-risk infants demonstrated the same level of cause and effect learning skills when compared to low-risk infants of the same age.
Validus Medical Systems, Inc., a privately held healthcare IT firm founded by veteran entrepreneur David Kashtan (Network Alchemy, TGV Software), formally launched its breakthrough bi-directional mobile software solution for hospital systems. The Validus inTouchTM software system was developed by Kashtan, a team of leading physicians, software engineers, cloud computing experts, and network security specialists to improve the quality, safety and efficiency of healthcare.
All COVID-19 vaccines appear less effective when faced with variants such as Delta, according to a new medRxiv* study. However, the researchers suggest that booster shots may help improve immunity and protect against symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
› Verified 6 days ago
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
A red dye derived from lichens that has been used for centuries to color fabrics and food appears to reduce the abundance of small toxic protein aggregates in Alzheimer's disease. The dye, a compound called orcein, and a related substance, called O4, bind preferentially to small amyloid aggregates that are considered to be toxic and cause neuronal dysfunction and memory impairment in Alzheimer's disease.
Kennedy Krieger Institute announced today new study results showing an early marker for later communication and social delays in infants at a higher-risk for autism may be infrequent gazing at other people when unprompted. Published in the September issue of the Journal of Child Psychology and Psychiatry, the study also found that six-month-old high-risk infants demonstrated the same level of cause and effect learning skills when compared to low-risk infants of the same age.
Validus Medical Systems, Inc., a privately held healthcare IT firm founded by veteran entrepreneur David Kashtan (Network Alchemy, TGV Software), formally launched its breakthrough bi-directional mobile software solution for hospital systems. The Validus inTouchTM software system was developed by Kashtan, a team of leading physicians, software engineers, cloud computing experts, and network security specialists to improve the quality, safety and efficiency of healthcare.
All COVID-19 vaccines appear less effective when faced with variants such as Delta, according to a new medRxiv* study. However, the researchers suggest that booster shots may help improve immunity and protect against symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
› Verified 6 days ago
| Entity Name | Vermont Gynecology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174830251 PECOS PAC ID: 0244428357 Enrollment ID: O20101215001181 |
News Archive
A red dye derived from lichens that has been used for centuries to color fabrics and food appears to reduce the abundance of small toxic protein aggregates in Alzheimer's disease. The dye, a compound called orcein, and a related substance, called O4, bind preferentially to small amyloid aggregates that are considered to be toxic and cause neuronal dysfunction and memory impairment in Alzheimer's disease.
Kennedy Krieger Institute announced today new study results showing an early marker for later communication and social delays in infants at a higher-risk for autism may be infrequent gazing at other people when unprompted. Published in the September issue of the Journal of Child Psychology and Psychiatry, the study also found that six-month-old high-risk infants demonstrated the same level of cause and effect learning skills when compared to low-risk infants of the same age.
Validus Medical Systems, Inc., a privately held healthcare IT firm founded by veteran entrepreneur David Kashtan (Network Alchemy, TGV Software), formally launched its breakthrough bi-directional mobile software solution for hospital systems. The Validus inTouchTM software system was developed by Kashtan, a team of leading physicians, software engineers, cloud computing experts, and network security specialists to improve the quality, safety and efficiency of healthcare.
All COVID-19 vaccines appear less effective when faced with variants such as Delta, according to a new medRxiv* study. However, the researchers suggest that booster shots may help improve immunity and protect against symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca M Montgomery, CNM 784 Hercules Dr Ste 110, Colchester, VT 05446-5838 Ph: (802) 448-9719 | Rebecca M Montgomery, CNM 90 Washington St, Barre, VT 05641-4239 Ph: (802) 476-6696 |
News Archive
A red dye derived from lichens that has been used for centuries to color fabrics and food appears to reduce the abundance of small toxic protein aggregates in Alzheimer's disease. The dye, a compound called orcein, and a related substance, called O4, bind preferentially to small amyloid aggregates that are considered to be toxic and cause neuronal dysfunction and memory impairment in Alzheimer's disease.
Kennedy Krieger Institute announced today new study results showing an early marker for later communication and social delays in infants at a higher-risk for autism may be infrequent gazing at other people when unprompted. Published in the September issue of the Journal of Child Psychology and Psychiatry, the study also found that six-month-old high-risk infants demonstrated the same level of cause and effect learning skills when compared to low-risk infants of the same age.
Validus Medical Systems, Inc., a privately held healthcare IT firm founded by veteran entrepreneur David Kashtan (Network Alchemy, TGV Software), formally launched its breakthrough bi-directional mobile software solution for hospital systems. The Validus inTouchTM software system was developed by Kashtan, a team of leading physicians, software engineers, cloud computing experts, and network security specialists to improve the quality, safety and efficiency of healthcare.
All COVID-19 vaccines appear less effective when faced with variants such as Delta, according to a new medRxiv* study. However, the researchers suggest that booster shots may help improve immunity and protect against symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
› Verified 6 days ago